Donepezil use in children and adolescents with tics and attention-deficit/hyperactivity disorder: An 18-week, single-center, dose-escalating, prospective, open-label study

Clinical Therapeutics

Volumn 30, Issue 1, 2008, Pages 182-189

  Cubo, Esther ^a,b   Fernndez Jaén, Alberto ^a   Moreno, Celia ^a   Anaya, Belén ^a   Gonzlez, Miguel ^c   Kompoliti, Katie ^d  

^a Neurology Department   (Spain)

^b HOSPITAL UNIVERSITARIO DE BURGOS   (Spain)

^c UNIVERSITY OF EXTREMADURA   (Spain)

^d RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

attention deficit hyperactivity disorder; donepezil.; tics; Tourette's syndrome

Indexed keywords

DONEPEZIL;

ADOLESCENT; ARTICLE; ATTENTION DEFICIT DISORDER; CHILDREN GLOBAL ASSESSMENT SCALE; CHILDREN YALE BROWN OBSESSIVE COMPULSIVE SCALE; CHRONIC DISEASE; CLINICAL TRIAL; COMORBIDITY; DISEASE SEVERITY; DIZZINESS; DRUG DOSE INCREASE; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; GASTROINTESTINAL SYMPTOM; GILLES DE LA TOURETTE SYNDROME; HEADACHE; HUMAN; IRRITABILITY; MAJOR CLINICAL STUDY; MALE; MOOD DISORDER; NIGHTMARE; OPEN STUDY; PROSPECTIVE STUDY; PSYCHOLOGIC TEST; RATING SCALE; REVISED CONNERS PARENT RATING SCALE; REY COMPLEX FIGURE TEST; SCHOOL CHILD; SEDATION; SIDE EFFECT; STROOP TEST; TIC; URINE INCONTINENCE; WISCONSIN CARD SORTING TEST; YALE GLOBAL TIC SEVERITY SCALE;

ADOLESCENT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD; CHOLINESTERASE INHIBITORS; COMORBIDITY; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; INDANS; MALE; PILOT PROJECTS; PIPERIDINES; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TIC DISORDERS;

EID: 45149114783     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2008.01.010     Document Type: Article

References (36)

1. Singer H. Tourette's syndrome: From behaviour to biology. Lancet Neurol 4 (2005) 149-159
2. Khalifa N., and von Knorring A. Tourette syndrome and other tic disorders in a total population of children: Clinical assessment and background. Acta Paediatr 94 (2005) 1608-1614
3. Leckman J. Phenomenology of tics and natural history of tic disorders. Brain Dev 25 Suppl 1 (2003) S24-S28
4. Zausmer D. The treatment of tics in childhood: A review and a follow-up study. Arch Dis Child 29 (1954) 537-542
5. Burd L., Freeman R., Klug M., and Kebershian J. Tourette syndrome and learning disabilities. BMC Pediatrics 5 (2005) 34
6. Swain J., Scahill L., Lombroso P., et al. Tourette syndrome and tic disorders: A decade of progress. J Am Acad Child Adolesc Psychiatry 46 (2007) 947-968
7. Arnsten A., Scahill L., and Findling R. Alpha2-adrenergic receptor agonists for the treatment of attention-deficit/hyperactivity disorder: Emerging concepts from new data. J Child Adolesc Psychopharmacol 17 (2007) 393-406
8. Robertson M. Attention deficit hyperactivity disorder, tics and Tourette's syndrome: The relationship and treatment implications. A commentary. Eur Child Adolesc Psychiatry 15 (2006) 1-11
9. Pliszka S. Non-stimulant treatment of attention-deficit/hyperactivity disorder. CNS Spectr 8 (2003) 253-258
10. Wolraich M., McGuinn L., and Doffing M. Treatment of attention deficit hyperactivity disorder in children and adolescents: Safety considerations. Drug Saf 30 (2007) 17-26
11. Frazier J., Cohen L., Jacobsen L., et al. Clozapine pharmacokinetics in children and adolescents with childhood-onset schizophrenia. Clin Psychopharmacol 23 (2003) 87-91
12. Goodnick P., Rodriguez L., and Santana O. Antipsychotics: Impact on prolactin levels. Expert Opin Pharmacother 3 (2002) 1381-1391
13. Tanner C., Goetz C., and Klawans H. Cholinergic mechanisms in Tourette syndrome. Neurology 32 (1982) 1315-1317
14. Stahl S., and Berger P. Physostigmine in Tourette syndrome: Evidence for cholinergic underactivity. Am J Psychiatry 138 (1981) 240-242
15. Hayslett R., and Tizabi Y. Effects of donepezil on DOI-induced head twitch response in mice: Implications for Tourette syndrome. Pharmacol Biochem Behav 76 (2003) 409-415
16. Riback P. Donepezil for tics in Tourette syndrome. Ann Neurol 50 Suppl 3 (2001) 117 Abstract
17. Hoopes S. Donepezil for Tourette's disorder and ADHD. J Clin Psychopharmacol 19 (1999) 381-382
18. Wilens T., Biederman J., Wong J., et al. Adjunctive donepezil in attention deficit hyperactivity disorder youth: Cases series. J Child Adolesc Psycho-pharmacol 10 (2000) 217-222
19. Rogers S., Farlow M., Doody R., et al. A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Neurology 50 (1998) 136-145
20. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR) (2000), Va: American Psychiatric Association, Arlington
21. Conners C., Sitarenios G., Parker J., and Epstein J. The revised Conners' Parent Rating Scale (CPRS-R): Factor structure, reliability, and criterion validity. J Abnorm Child Psychol 26 (1998) 257-268
22. Wilens T., Waxmonsky J., Scott M., et al. An open trial of adjunctive donepezil in attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol 15 (2005) 947-955
23. Shaffer D., Gould M., Brasic J., et al. A Children's Global Assessment Scale (CGAS). Arch Gen Psychiatry 40 (1983) 1228-1231
24. Leckman J., Riddle M., Hardin M., et al. The Yale Global Tic Severity Scale: Initial testing of a clinician-rated scale of tic severity. J Am Acad Child Adolesc Psychiatry 28 (1989) 566-573
25. Schneider S., and Asarnow R. A comparison of cognitive/neuropsychological impairments of nonretarded autistic and schizophrenic children. J Abnorm Child Psychol 15 (1987) 29-45
26. Stroop J. Studies of interference in serial verbal reaction. Exp Psychol 18 (1935) 643
27. Lanzi G., Taraschi G., and Tassarotti B. Perception and memory after a cycle of electroshocks, studied by means of the Rey figure complex test. II. Application of the Rey test in a group of patients before and after a cycle of electroshocks. Comparison with the results obtained in control subjects. [in Italian]. Riv Patol Nerv Ment 86 (1965) 729-765
28. Scahill L., Riddle M., McSwiggin-Hardin M., et al. Children's Yale-Brown Obsessive Compulsive Scale: Reliability and validity. J Am Acad Child Adolesc Psychiatry 36 (1997) 844-852
29. The R Project for Statistical Computing [R-project.org Web site]. http://www.R-project.org Accessed June 2004.
30. Hayslett R., and Tizabi Y. Effects of donepezil, nicotine and haloperidol on the central serotoninergic system in mice: Implications for Tourette's syndrome. Pharmacol Biochem Behav 81 (2005) 879-886
31. Como P., LaMarsh J., and O'Brien K. Obsessive-compulsive disorder in Tourette's syndrome. Adv Neurol 96 (2005) 249-261
32. Doyle R., Frazier J., Spencer T., et al. Donepezil in the treatment of ADHD-like symptoms in youths with pervasive developmental disorder: A case series. J Atten Disord 9 (2006) 543-549
33. Sarter M., and Bruno J. Cortical cholinergic inputs mediating arousal, attentional processing and dreaming: Differential afferent regulation of the basal forebrain by telencephalic and brainstem afferents. Neuroscience 95 (2000) 933-952
34. Heller J., Spiridigliozzi G., Dorai-swamy P., et al. Donepezil effects on language in children with Down syndrome: Results of the first 22-week pilot clinical trial. Am J Med Genet A 130 (2004) 325-326
35. McCain K., Sawyer T., and Spiller H. Evaluation of centrally acting cholinesterase inhibitor exposures in adults. Ann Pharmacother 41 (2007) 1632-1637
36. Lejus C., Delaroche O., Trille E., et al. Butyrylcholinesterase deficiency: How to analyze the cholinesterase activity in small children. [in French]. Ann Fr Anesth Reanim 25 (2006) 657-660